As a clinical trial sponsor, you were already facing tight timelines and resource constraints in handling regulatory requirements for document anonymization and redaction.
Now, with increasing pressure to protect commercially confidential information (CCI) and mandatory compliance with EU Clinical Trials Regulation (EU CTR) coming on Jan 31, 2023, you’ll need to handle increased transparency demands on top of existing requirements under Health Canada Public Release of Clinical Information (PRCI) and future requirements under EMA Policy 0070.
The good news is we can help you safely accelerate submissions and protect the CCI you’ve identified for the broader range of clinical document types you now need to address throughout the trial application process.
Join Niamh McGuinness, Senior Manager of Clinical Trial Transparency and Privacy, Privacy Analytics, on October 13 to learn about three solution options to help you meet your regulatory submission deadlines while protecting patient privacy and CCI. You’ll also see a demo of Mirage software, the natural language processing-powered tech behind each solution.
Sign up for either session (or both) and find out which solution best meets your most pressing clinical document submission needs: Redaction-as-a-Service, Anonymization-as-a-Service, or a license option.
Thursday, October 13
8 a.m. ET / 2 p.m. CET – Live Webinar + Q&A (30 min.)
11 a.m. ET / 5 p.m. CET – Live Webinar + Q&A (30 min.)